Crowdonomics
WatchlistPortfolio
Transatlantic Real Estate LLC

Reg CF · Debt · Sep 2018

ClosedReached targetReg CFDebt
via truCrowd, Inc · last checked Aug 17, 2026
Raised
$866.8K / $1.1M max
81% of ceiling
Investors
1,642
$527.9 avg
Valuation
—
—

Financials disclosed in this offering

FY2016–FY2017 · hover for source
$0
FY2016
$0
FY2017
RevenueNet income
Metric
FY2016 reviewed*
FY2017 reviewed*
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
$0
$0
Taxes paid
$0
$0
Balance sheet
Cash
$0
$0
Accounts receivable
$0
$0
Total assets
$0
$0
Short-term debt
$0
$0
Long-term debt
$0
$0
Total liabilities
$0
$0
Other
Headcount
—
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

5 amendments
  1. Dec 24, 2018
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Nov 20, 2018
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  3. Oct 5, 2018
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  4. Sep 21, 2018
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  5. Sep 18, 2018
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$10,000
Max$1,070,000
Min investment—
OpenedSep 12, 2018
DeadlineJan 31, 2019
ClosedJan 31, 2019
Days active141

Links & provenance

SEC filing
Source: SEC EDGAR
0001751443-18-000001
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.